These findings confirm the existence of a CD24+CD271+ sub-population that localises to the invasive front in human melanoma but, in agreement with our panel of melanoma cell lines, is only present in a minority (3/31, 10%) of tumours. This evidence concerns the gene NGFR and neoplasm.